First Trust Amex Biotech Index Fund (FBT): Price and Financial Metrics ETF
FBT Price/Volume Stats - 7 Best ETFs for the NEXT Bull Market
| Current price | $178.24 | 52-week high | $179.67 |
| Prev. close | $172.99 | 52-week low | $140.36 |
| Day low | $174.23 | Volume | 20,491 |
| Day high | $178.37 | Avg. volume | 30,033 |
| 50-day MA | $170.92 | Dividend yield | 0.68% |
| 200-day MA | $162.93 |
FBT Stock Price Chart Interactive Chart >
First Trust Amex Biotech Index Fund (FBT) ETF Bio
The investment objective of the First Trust Amex Biotech Index Fund ETF seeks to measure the performance of a cross section of companies in the biotechnology industry that are primarily involved in the use of biological processes to develop products or provide services.
FBT ETF Info
| Issuer | First Trust Portfolios |
| Expense Ratio | 0.55% |
| Underlying Index | NYSE Arca Biotechnology Index |
| Asset Class | Equity |
| Sector | Health & Biotech ETFs |
| Assets Under Management (AUM) | 1.17B |
| Net Asset Value (NAV) | $172.85 |
| Options? | Yes |
| Total Holdings | 32 |
FBT Top Holdings
| Symbol | Company | % of Total |
| EXEL | Exelixis Inc. | 4.59% |
| NTRA | Natera Inc. | 4.5% |
| ITCI | Intra-Cellular Therapies Inc. | 4.19% |
| ARGX | argenx SE (ADR) | 4.09% |
| NBIX | Neurocrine Biosciences Inc. | 4.08% |
| ACAD | ACADIA Pharmaceuticals Inc. | 3.87% |
| RGEN | Repligen Corporation | 3.73% |
| CORT | Corcept Therapeutics Inc. | 3.67% |
| CPRX | Catalyst Pharmaceuticals Inc. | 3.63% |
| INCY | Incyte Corporation | 3.57% |
FBT Price Returns
| 1-mo | 7.68% |
| 3-mo | 6.34% |
| 6-mo | 8.86% |
| 1-year | 17.83% |
| 3-year | 24.57% |
| 5-year | 22.54% |
| YTD | 7.24% |
| 2024 | 5.88% |
| 2023 | 2.55% |
| 2022 | -4.83% |
| 2021 | -2.26% |
| 2020 | 12.96% |
FBT Dividends
| Ex-Dividend Date | Type | Payout Amount | Change | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||